| Literature DB >> 27773571 |
Keqiang Xie1, Lesley A Colgan2, Maria T Dao3, Brian S Muntean1, Laurie P Sutton1, Cesare Orlandi1, Sanford L Boye4, Shannon E Boye4, Chien-Cheng Shih1, Yuqing Li5, Baoji Xu1, Roy G Smith3, Ryohei Yasuda2, Kirill A Martemyanov6.
Abstract
It is well recognized that G-protein-coupled receptors (GPCRs) can activate Ras-regulated kinase pathways to produce lasting changes in neuronal function. Mechanisms by which GPCRs transduce these signals and their relevance to brain disorders are not well understood. Here, we identify a major Ras regulator, neurofibromin 1 (NF1), as a direct effector of GPCR signaling via Gβγ subunits in the striatum. We find that binding of Gβγ to NF1 inhibits its ability to inactivate Ras. Deletion of NF1 in striatal neurons prevents the opioid-receptor-induced activation of Ras and eliminates its coupling to Akt-mTOR-signaling pathway. By acting in the striatal medium spiny neurons of the direct pathway, NF1 regulates opioid-induced changes in Ras activity, thereby sensitizing mice to psychomotor and rewarding effects of morphine. These results delineate a novel mechanism of GPCR signaling to Ras pathways and establish a critical role of NF1 in opioid addiction.Entities:
Keywords: G proteins; GPCR signaling; addiction; neurofibromatosis; opioids; striatum
Mesh:
Substances:
Year: 2016 PMID: 27773571 PMCID: PMC5121064 DOI: 10.1016/j.cub.2016.09.010
Source DB: PubMed Journal: Curr Biol ISSN: 0960-9822 Impact factor: 10.834